76 related articles for article (PubMed ID: 9772705)
21. Pharmacokinetics of acyclovir in rabbit skin after i.v.-bolus, ointment, and iontophoretic administrations.
Stagni G; Ali ME; Weng D
Int J Pharm; 2004 Apr; 274(1-2):201-11. PubMed ID: 15072796
[TBL] [Abstract][Full Text] [Related]
22. Tc-NGA imaging in liver transplantation: preclinical studies.
Woodle ES; Vera DR; Stadalnik RC; Ward RE
Surgery; 1987 Jul; 102(1):55-62. PubMed ID: 3296267
[TBL] [Abstract][Full Text] [Related]
23. In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits.
Anand BS; Katragadda S; Gunda S; Mitra AK
Mol Pharm; 2006; 3(4):431-40. PubMed ID: 16889437
[TBL] [Abstract][Full Text] [Related]
24. [Study on liver targeted valaciclovir polybutylcyanoacrylate nanoparticles].
Zhang Z; He Q
Yao Xue Xue Bao; 1998 Sep; 33(9):702-6. PubMed ID: 12016876
[TBL] [Abstract][Full Text] [Related]
25. Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir.
Zhou Y; Wei YH; Zhang GQ; Wu XA
Arch Pharm Res; 2010 Apr; 33(4):567-74. PubMed ID: 20422366
[TBL] [Abstract][Full Text] [Related]
26. Self-assembled drug delivery systems. 1. Properties and in vitro/in vivo behavior of acyclovir self-assembled nanoparticles (SAN).
Jin Y; Tong L; Ai P; Li M; Hou X
Int J Pharm; 2006 Feb; 309(1-2):199-207. PubMed ID: 16377106
[TBL] [Abstract][Full Text] [Related]
27. Liver targeting and anti-HBV activity of reconstituted HDL-acyclovir palmitate complex.
Feng M; Cai Q; Huang H; Zhou P
Eur J Pharm Biopharm; 2008 Mar; 68(3):688-93. PubMed ID: 17890068
[TBL] [Abstract][Full Text] [Related]
28. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
Kudo M; Vera DR; Trudeau WL; Stadalnik RC
J Nucl Med; 1991 Jun; 32(6):1177-82. PubMed ID: 2045931
[TBL] [Abstract][Full Text] [Related]
29. Intravenous infusion of cereport increases uptake and efficacy of acyclovir in herpes simplex virus-infected rat brains.
Bidanset DJ; Placidi L; Rybak R; Palmer J; Sommadossi JP; Kern ER
Antimicrob Agents Chemother; 2001 Aug; 45(8):2316-23. PubMed ID: 11451691
[TBL] [Abstract][Full Text] [Related]
30. [Pharmacokinetic studies on 99mTc-NGA in human].
Guan C; Chen Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):268-70. PubMed ID: 8288194
[TBL] [Abstract][Full Text] [Related]
31. Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea.
Majumdar S; Hippalgaonkar K; Repka MA
Int J Pharm; 2008 Feb; 348(1-2):175-8. PubMed ID: 17897799
[TBL] [Abstract][Full Text] [Related]
32. Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; DeClercq E; El-Shattawy HH
J Pharm Sci; 1999 May; 88(5):530-4. PubMed ID: 10229644
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of valacyclovir in the adult horse.
Maxwell LK; Bentz BG; Bourne DW; Erkert RS
J Vet Pharmacol Ther; 2008 Aug; 31(4):312-20. PubMed ID: 18638291
[TBL] [Abstract][Full Text] [Related]
34. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium.
Anand BS; Katragadda S; Nashed YE; Mitra AK
Curr Eye Res; 2004; 29(2-3):153-66. PubMed ID: 15512962
[TBL] [Abstract][Full Text] [Related]
35. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies.
Vera DR; Stadalnik RC; Krohn KA
J Nucl Med; 1985 Oct; 26(10):1157-67. PubMed ID: 4045560
[TBL] [Abstract][Full Text] [Related]
36. [The preparation of 99mTc-NGA instant lyophilized kit for hepatic imaging].
Guan C; Chen Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):429-32. PubMed ID: 8150449
[TBL] [Abstract][Full Text] [Related]
37. Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Wien Klin Wochenschr; 1991; 103(15):458-61. PubMed ID: 1926872
[TBL] [Abstract][Full Text] [Related]
38. Studies on acyclovir-dextran conjugate: synthesis and pharmacokinetics.
Tu J; Zhong S; Li P
Drug Dev Ind Pharm; 2004; 30(9):959-65. PubMed ID: 15554220
[TBL] [Abstract][Full Text] [Related]
39. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
[TBL] [Abstract][Full Text] [Related]
40. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.
Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
